# P190011: LIAISON XL MUREX HCV Ab; LIAISON XL MUREX Control HCV Ab

- Pathway: PMA
- Applicant: DiaSorin, Inc.
- Decided: Oct 18, 2019 after 179 days
- Product code: MZO (Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus)
- Device class: 2
- Regulation: 21 CFR 866.3169
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
2 later devices descend from it; 2 cite it directly.
0 of 3 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. PMA decisions do not claim a predicate device.

## Most influential descendants
- K262156: Anti-HCV Next (2026), 0 descendants of its own
- K252424: Anti-HCV Next (2026), 0 descendants of its own

Source page: https://510kreport.com/device/P190011
Methodology: https://510kreport.com/methodology